Home   >  
GPCR/G Protein
  >  
Leukotriene Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Leukotriene Receptor

Chemical Structure Cat. No. Product Name CAS No.
LY255283 Chemical Structure
 BCP45104 LY255283 117690-79-6
LY255283 is a LTB4 receptor (BLT2) antagonist, with an IC50 of ~100 nM for [3H]LTB4 binding to guinea pig lung membranes.
SC 57461A Chemical Structure
 BCP36043 SC 57461A 423169-68-0
SC 57461A is a potent and competitive inhibitor of recombinant human leukotriene A4 hydrolase in vitro.
LYS-006 Chemical Structure
 BCP35741 LYS-006 1799681-85-8
LYS-006 is a novel leukotriene A4 hydrolase inhibitor.
11-Keto-beta-boswellic acid Chemical Structure
 BCP32934 11-Keto-beta-boswellic acid 17019-92-0
11-Keto-beta-boswellic acid is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense.
Cilastatin Chemical Structure
 BCP21135 Cilastatin 82009-34-5
Cilastatin is a Renal Dehydropeptidase Inhibitor. The mechanism of action of cilastatin is as a Dipeptidase Inhibitor.
Montelukast Chemical Structure
 BCP28542 Montelukast 158966-92-8
Montelukast is a Leukotriene Receptor Antagonist. The mechanism of action of montelukast is as a Leukotriene Receptor Antagonist.
Montelukast Sulfone Chemical Structure
 BCP27889 Montelukast Sulfone 1266620-74-9
Montelukast Sulfone is an impurity of Montelukast Sodium.
Tipelukast Chemical Structure
 BCP17000 Tipelukast 125961-82-2
Tipelukast is a sulfidopeptide leukotriene receptor antagonist, an orally bioavailable anti-inflammatory agent and used for the treatment of asthma.
CP-105696 Chemical Structure
 BCP30009 CP-105696 158081-99-3
CP-105696 is a potent and selective Leukotriene B4 Receptor antagonist, with an IC50 of 8.42 nM.
L-660711 Chemical Structure
 BCP30001 L-660711 135028-15-8
MK-571 is a selective, orally active CysLT1 receptor antagonist. It blocks the binding of LTD4, but not LTC4, to human and guinea pig lung membranes with Ki values of 0.22 nM and 2.1 nM, respectively. MK-571 attenuates kidney ischemia and reperfusion-induced airway hypersensitivity in rats. MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
123下一页共 27 条记录 1 / 3 页 
0086-13720134139